ATRECA, INC. EXECUTIVE EMPLOYMENT AGREEMENT for Susan BerlandExecutive Employment Agreement • April 24th, 2019 • Atreca, Inc. • Pharmaceutical preparations • California
Contract Type FiledApril 24th, 2019 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), made between Atreca, Inc. (the “Company”) and Susan Berland (the “Executive”) (collectively, the “Parties”), is effective as of April 19 , 2016.
ATRECA, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTRights Agreement • April 24th, 2019 • Atreca, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 24th, 2019 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is entered into as of September 5, 2018, by and among Atreca, Inc., a Delaware corporation (the “Company”), and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”
ATRECA, INC. WARRANT TO PURCHASE SERIES A PREFERRED STOCKAtreca, Inc. • April 24th, 2019 • Pharmaceutical preparations • Delaware
Company FiledApril 24th, 2019 Industry JurisdictionTHIS CERTIFIES THAT, for value received, , or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from ATRECA, INC., a Delaware corporation, with its principal office at 500 Saginaw Dr., Redwood City, California 94063 (the “Company”) the Exercise Shares at the Exercise Price (each subject to adjustment as provided herein). This Warrant is being issued as one of a series of warrants (the “Warrants”) pursuant to that certain Placement Agency Agreement, dated March 25, 2015, by and between Brookline Group, LLC (“Brookline”) and the Company (the “Agreement”) in full satisfaction of the provisions of Section 3(e) thereof and pursuant to that certain Preferred Warrant Assignment Form, dated November 9, 2015, by and between Brookline and the Company (the “Assignment”). The aggregate number of Exercise Shares that Holder may purchase by exercising this warrant is shares of the Company’s Series A Preferred Stock (subject to adjustment pursuant
ATRECA, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT for Tito SerafiniExecutive Employment Agreement • April 24th, 2019 • Atreca, Inc. • Pharmaceutical preparations • California
Contract Type FiledApril 24th, 2019 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement (the “Agreement”), made between Atreca, Inc. (the “Company”) and Tito Serafini (the “Executive”) (collectively, the “Parties”), is effective as of date all parties have signed this Agreement (the “Effective Date”).
ATRECA, INC. EXECUTIVE EMPLOYMENT AGREEMENT for John OrwinExecutive Employment Agreement • April 24th, 2019 • Atreca, Inc. • Pharmaceutical preparations • California
Contract Type FiledApril 24th, 2019 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), made between Atreca, Inc. (the “Company”) and John Orwin (the “Executive”) (collectively, the “Parties”), is effective as of March 21, 2018 (“Effective Date”).